Endoscopic Sleeve Gastroplasty for Obesity – First Indian Experience: Case Series and Review of Literature

ABSTRACT

Introduction: In India, obesity affects >135 million and leads to nearly 5.8 million deaths per year. Some of the unmet need in the management of obesity can be fulfilled by endoscopic therapies such as endoscopic sleeve gastroplasty (ESG). Methods: In this case series, we report our preliminary experience of ESG in three obese patients. We recorded baseline demographic data, total procedural time, adverse events, and percentage total body weight loss (%TBWL) up to 20 weeks. Results: All three patients were male with a median age of 29 years (range 26–39) with a median body mass index of 34.28 kg/m2 (range 32.60–37.13). A total of four full‑thickness and additional three submucosal sutures were applied in each patient. There were no adverse events. The median total procedural time was 105 min (range 90–150). All patients were discharged within 48 h. The median percentage total body weight loss (%TBWL) at 12 weeks was 12.02 (range 10.85–13.33) and at 16 weeks was 14.23 (range 13.84–14.62). The maximum follow‑up so far is 20 weeks (one patient) with %TBWL of 16.38. Conclusion: In our preliminary experience, we conclude that ESG is safe, effective and requires shorter hospital stay. In short‑term follow‑up, there is adequate weight loss without major adverse events.

KEYWORDS

Endoscopic sleeve gastroplasty - endoscopic therapy - metabolic syndrome - obesity - weight loss

• REFERENCES

• 1 Shrivastava U, Misra A, Mohan V, Unnikrishnan R, Bachani D. Obesity, diabetes and cardiovascular diseases in India: Public health challenges. Curr Diabetes Rev 2017; 13: 65-80
• 2 Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK. et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5: 585-96
• 3 Abu Dayyeh BK, Edmundowicz S, Thompson CC. Clinical practice update: Expert review on endoscopic bariatric Therapies. Gastroenterology 2017; 152: 716-29
• 4 ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N. et al. Endoscopic bariatric therapies. Gastrointest Endosc 2015; 81: 1073-86
• 5 Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: New and emerging technologies. Gastroenterology 2017; 152: 1791-801
• 6 Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, Galvao Neto MP, Sahdala NP, Shaikh SN. et al. Endoscopic sutured gastroplasty: Procedure evolution from first-in-man cases through current technique. Surg Endosc 2018; 32: 2159-64
• 7 Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castaño I. et al. Endoscopic sleeve gastroplasty for obesity: A multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017; 27: 2649-55
• 8 Hill C, El Zein M, Agnihotri A, Dunlap M, Chang A, Agrawal A. et al. Endoscopic sleeve gastroplasty: The learning curve. Endosc Int Open 2017; 5: E900-4
• 9 Saumoy M, Schneider Y, Zhou XK, Shukla A, Kahaleh M, Aronne L. et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc 2018; 87: 442-7
• 10 Novikov AA, Afaneh C, Saumoy M, Parra V, Shukla A, Dakin GF. et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: How do they compare?. J Gastrointest Surg 2018; 22: 267-73
• 11 Lopez-Nava G, Galvão MP, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty: How I do it?. Obes Surg 2015; 25: 1534-8
• 12 Sharaiha RZ, Kumta NA, Saumoy M, Desai AP, Sarkisian AM, Benevenuto A. et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 2017; 15: 504-10